Amedisys Announces Second Quarter Earnings Release and Conference Call Date
July 26 2016 - 3:00PM
Amedisys, Inc. (NASDAQ:AMED), one of America’s leading home health
and hospice care companies, announced today that it will report
results for the second quarter ended June 30, 2016 after the market
closes on August 2, 2016. The Company will host an investor
conference call to discuss these results at 11:00 a.m. ET on August
3, 2016.
To participate on the conference call, please call a few minutes
before 11:00 a.m. ET to either (877) 524-8416 (Toll-Free) or (412)
902-1028 (Toll). A replay of the conference call will be
available through September 3, 2016. The replay dial-in
number is (877) 660-6853 (Toll-Free) or (201) 612-7415 (Toll) and
reference conference ID #13641920.
A live webcast of the call will be accessible
through our website on our Investor Relations section at the
following web address: http://investors.amedisys.com.
Amedisys, Inc. (the “Company”) is headquartered
in Baton Rouge, Louisiana with an executive office in Nashville,
Tennessee and our common stock trades on the NASDAQ Global Select
Market under the symbol “AMED”.
About Amedisys: Amedisys, Inc. is a leading
healthcare at home Company delivering personalized home health,
hospice and personal care. Amedisys is focused on delivering the
care that is best for our patients, whether that is home-based
personal care; recovery and rehabilitation after an operation or
injury; care focused on empowering them to manage a chronic
disease; or hospice care at the end of life. More than 2,200
hospitals and 61,900 physicians nationwide have chosen Amedisys as
a partner in post-acute care. Founded in 1982, headquartered in
Baton Rouge, LA with an executive office in Nashville, TN, Amedisys
is a publicly held company. With more than 16,000 employees, in 421
care centers in 34 states, Amedisys is dedicated to delivering the
highest quality of care to the doorsteps of more than 340,000
patients in need every year. For more information about the
Company, please visit: www.amedisys.com.
We use our company website as a channel of
distribution for important company information. Important
information, including press releases, analyst presentations and
financial information regarding the Company is routinely posted on
and accessible on the "Investor Relations" subpage of our website,
which is accessible by clicking on the tab labeled "Investors" on
our website home page. We will also use our website to expedite
public access to time-critical information regarding the Company in
advance of or in lieu of distributing a press release or a filing
with the Securities and Exchange Commission ("SEC") disclosing the
same information. In addition, we make available on the Investor
Relations subpage of our website (under the link "SEC filings")
free of charge our annual reports on Form 10-K, quarterly reports
on Form 10-Q, current reports on Form 8-K, ownership reports on
Forms 3, 4 and 5 and any amendments to those reports as soon as
practicable after we electronically file such reports with the SEC.
Further, copies of our Certificate of Incorporation and Bylaws, our
Code of Ethical Business Conduct and the charters for the Audit,
Compensation, Nominating and Corporate Governance, Quality of Care
and Compliance and Ethics Committees of our Board are also
available on the Investor Relations subpage of our website (under
the link "Corporate Governance").
Contact:
Amedisys, Inc.
David Castille
Managing Director, Finance and Assistant Treasurer
225.299.3665
david.castille@amedisys.com
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amedisys (NASDAQ:AMED)
Historical Stock Chart
From Sep 2023 to Sep 2024